UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Septic shock due to 'Myroides odoratus' in a medical intensive care unit patient with severe necrotising pancreatitis

Anaesthesia and intensive care, 2016-03, Vol.44 (2), p.1-2

2016

Volltextzugriff (PDF)

Role of RAS-dependent signaling pathways in hepatic carcinogenesis

Journal of hepatology, 2017, Vol.66 (1), p.S225-S226

2017

Volltextzugriff (PDF)

O103 : Metastasis development in a novel mouse model of advanced liver cancer

Journal of hepatology, 2015-04, Vol.62, p.S245-S245

2015

Volltextzugriff (PDF)

896 REDEFINING TRANSIENT UNCONJUGATED HYPERBILIRUBINEMIA: GILBERTS SYNDROME REPRESENTS A COMPLEX GENETIC SYNDROME IMPACTING GLUCURONIDATION ACTIVITY

Journal of hepatology, 2011-03, Vol.54, p.S357-S357

2011

Volltextzugriff (PDF)

876 COFFEE MEDIATED UPREGULATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASES

Journal of hepatology, 2010, Vol.52, p.S341-S342

2010

Volltextzugriff (PDF)

524 COORDINATE REGULATION OF THE HUMAN UDP- GLUCURONOSYLTRANFERASE 1A10 GENE BY ARYL HYDROCARBON RECEPTOR (AHR) AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 (NRF2)

Journal of hepatology, 2009, Vol.50, p.S195-S195

2009

Volltextzugriff (PDF)

713 THE REGULATION OF THE CARCINOGEN DETOXIFYING UDP-GLUCURONOSYLTRANSFERASE UGT1A7 BY 2,3,7,8-TETRACHLORDIBENZO-P-DIOXIN (TCDD) IS ALTERED BY A FUNCTIONAL PROMOTER VARIANT

Journal of hepatology, 2009, Vol.50, p.S261-S261

2009

Volltextzugriff (PDF)

261 FARNESOID X RECEPTOR-MEDIATED REGULATION OF THE HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A3 AND MODULATION BY URSODEOXYCHOLIC ACID

Journal of hepatology, 2009, Vol.50, p.S104-S104

2009

Volltextzugriff (PDF)

191P Evaluating sorafenib as second-line treatment for advanced hepatocellular carcinoma: SORA-2, an European retrospective multicenter study

Annals of oncology, 2024-06, Vol.35, p.S86-S86

2024

Volltextzugriff (PDF)

LBA37 IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)

Annals of oncology, 2021-09, Vol.32, p.S1312-S1312

2021

Volltextzugriff (PDF)

536 REGULATION OF HUMAN HEPATIC GLUCURONIDATION BY THIAZOLINDIONES VIA PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AND MODULATION BY GENETIC VARIANTS

Journal of hepatology, 2008, Vol.48, p.S201-S201

2008

Volltextzugriff (PDF)

912 REGULATION OF THE HUMAN UDP-GLUCURONOSYLTRANSFERASE UGT1A7 BY HEPATOCYTE NUCLEAR FACTOR 1 ALPHA (HNF1 ALPHA) AND HEPATOCYTE NUCLEAR FACTOR 4 ALPHA (HNF4 ALPHA)

Journal of hepatology, 2008, Vol.48, p.S342-S342

2008

Volltextzugriff (PDF)

535 FXR-MEDIATED REGULATION OF THE HUMAN HEPATIC BILE ACID UDP-GLUCURONOSYLTRANSFERASE (UGT) 1A3 GENE IN CHOLESTASIS

Journal of hepatology, 2008, Vol.48, p.S201-S201

2008

Volltextzugriff (PDF)

188P Early mortality in atezolizumab/bevacizumab for unresectable hepatocellular carcinoma: European, real-world study

Annals of oncology, 2024-06, Vol.35, p.S84-S85

2024

Volltextzugriff (PDF)

1007 GILBERT'S SYNDROME AND HYPERBILIRUBINEMIA IN PROTEASE INHIBITOR THERAPY – AN EXTENDED HAPLOTYPE OF GENETIC VARIANTS INCREASES RISK IN INDINAVIR TREATMENT

Journal of hepatology, 2009, Vol.50, p.S365-S365

2009

Volltextzugriff (PDF)

Hohe Zahl und Prävalenz von single nucleotide polymorphisms (SNP) des humanen UGT1A-Genlokus: genetische Grundlage der Variabilität humaner Glukuronidierung

Zeitschrift für Gastroenterologie, 2015, Vol.41 (8)

2015

Volltextzugriff (PDF)

[384] REGULATION VIA NUCLEAR RECEPTOR OF THE HUMAN UDP-GLUCURONOSYLTRANSFERASE (UGT) 1A3

Journal of hepatology, 2007, Vol.46, p.S149-S149

2007

Volltextzugriff (PDF)

SAT-187 - KRAS-dependent AKT signaling drives hepatocyte proliferation to promote tumor development in a genetic model of liver cancer

Journal of hepatology, 2018-04, Vol.68, p.S689-S689

2018

Volltextzugriff (PDF)

KRAS-dependent AKT signaling drives hepatocyte proliferation to promote tumor development in a genetic model of liver cancer

Journal of hepatology, 2018-04, Vol.68, p.S689

2018

Volltextzugriff (PDF)

THU-113 - Role of RAS-dependent signaling pathways in hepatic carcinogenesis

Journal of hepatology, 2017, Vol.66 (1), p.S225-S226

2017

Volltextzugriff (PDF)

Genetisches Risikoprofil beim hepatozellulärem Karzinom: Rolle von CYP1A1, UDP-Glukuronosyltransferasen und HFE-Gen

Zeitschrift für Gastroenterologie, 2015, Vol.41 (8)

2015

Volltextzugriff (PDF)

Of guinea pigs and men--an unusual case of jaundice

Zeitschrift fur Gastroenterologie, 2010-01, Vol.48 (1), p.33

2010

Volltextzugriff (PDF)

Entwicklung eines in vivo Transfektionsmodels zur induzierbaren Genexpression in murinen Hepatozyten

Zeitschrift für Gastroenterologie, 2015, Vol.53 (1)

2015

Volltextzugriff (PDF)

Metastasis development in a novel mouse model of advanced liver cancer

Zeitschrift für Gastroenterologie, 2015-01, Vol.53 (1)

2015

Volltextzugriff (PDF)

Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer

Zeitschrift für Gastroenterologie, 2002-07, Vol.40 (7), p.497-502

2002

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Septic shock due to 'Myroides odoratus' in a medical intensive care unit patient with severe necrotising pancreatitis

Role of RAS-dependent signaling pathways in hepatic carcinogenesis

O103 : Metastasis development in a novel mouse model of advanced liver cancer

896 REDEFINING TRANSIENT UNCONJUGATED HYPERBILIRUBINEMIA: GILBERTS SYNDROME REPRESENTS A COMPLEX GENETIC SYNDROME IMPACTING GLUCURONIDATION ACTIVITY

876 COFFEE MEDIATED UPREGULATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASES

524 COORDINATE REGULATION OF THE HUMAN UDP- GLUCURONOSYLTRANFERASE 1A10 GENE BY ARYL HYDROCARBON RECEPTOR (AHR) AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 (NRF2)

713 THE REGULATION OF THE CARCINOGEN DETOXIFYING UDP-GLUCURONOSYLTRANSFERASE UGT1A7 BY 2,3,7,8-TETRACHLORDIBENZO-P-DIOXIN (TCDD) IS ALTERED BY A FUNCTIONAL PROMOTER VARIANT

261 FARNESOID X RECEPTOR-MEDIATED REGULATION OF THE HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A3 AND MODULATION BY URSODEOXYCHOLIC ACID

191P Evaluating sorafenib as second-line treatment for advanced hepatocellular carcinoma: SORA-2, an European retrospective multicenter study

LBA37 IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)

536 REGULATION OF HUMAN HEPATIC GLUCURONIDATION BY THIAZOLINDIONES VIA PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AND MODULATION BY GENETIC VARIANTS

912 REGULATION OF THE HUMAN UDP-GLUCURONOSYLTRANSFERASE UGT1A7 BY HEPATOCYTE NUCLEAR FACTOR 1 ALPHA (HNF1 ALPHA) AND HEPATOCYTE NUCLEAR FACTOR 4 ALPHA (HNF4 ALPHA)

535 FXR-MEDIATED REGULATION OF THE HUMAN HEPATIC BILE ACID UDP-GLUCURONOSYLTRANSFERASE (UGT) 1A3 GENE IN CHOLESTASIS

188P Early mortality in atezolizumab/bevacizumab for unresectable hepatocellular carcinoma: European, real-world study

1007 GILBERT'S SYNDROME AND HYPERBILIRUBINEMIA IN PROTEASE INHIBITOR THERAPY – AN EXTENDED HAPLOTYPE OF GENETIC VARIANTS INCREASES RISK IN INDINAVIR TREATMENT

Hohe Zahl und Prävalenz von single nucleotide polymorphisms (SNP) des humanen UGT1A-Genlokus: genetische Grundlage der Variabilität humaner Glukuronidierung

[384] REGULATION VIA NUCLEAR RECEPTOR OF THE HUMAN UDP-GLUCURONOSYLTRANSFERASE (UGT) 1A3

SAT-187 - KRAS-dependent AKT signaling drives hepatocyte proliferation to promote tumor development in a genetic model of liver cancer

KRAS-dependent AKT signaling drives hepatocyte proliferation to promote tumor development in a genetic model of liver cancer

THU-113 - Role of RAS-dependent signaling pathways in hepatic carcinogenesis

Genetisches Risikoprofil beim hepatozellulärem Karzinom: Rolle von CYP1A1, UDP-Glukuronosyltransferasen und HFE-Gen

Of guinea pigs and men--an unusual case of jaundice

Entwicklung eines in vivo Transfektionsmodels zur induzierbaren Genexpression in murinen Hepatozyten

Metastasis development in a novel mouse model of advanced liver cancer

Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer

Suchergebnisse filtern